Pegasi integrates multi-modal health data to surface diagnostic signals weeks before conventional methods — giving oncology teams the clarity to act sooner.
Explore Solutions Request a DemoBuilt on clinical evidence, validated in real oncology workflows
Pegasi combines genomic markers, imaging biomarkers, and patient history into a single diagnostic score. Clinicians receive a consolidated view in under 90 seconds rather than reviewing disparate reports across three systems.
Our platform re-trains on each de-identified case outcome, refining sensitivity thresholds with every new data point. Current models achieve 94.2% sensitivity for Stage I detection across colorectal and lung cancer cohorts.
All patient data is processed in isolated, encrypted enclaves. Pegasi holds SOC 2 Type II certification and undergoes annual third-party penetration testing, supporting compliance across major US health systems.
Pegasi connects directly to Epic, Cerner, and Meditech via HL7 FHIR APIs. No duplicate data entry. No secondary logins. Diagnostic intelligence surfaces inside the workflow clinicians already use.
From raw data to clinical decision support in three steps
Pegasi pulls structured and unstructured data from your EHR, laboratory, and imaging systems via FHIR APIs — no manual exports or CSV uploads required.
Our multi-modal models cross-reference genomic variants, pathology reports, and clinical history against a curated oncology knowledge graph updated weekly.
Clinicians receive a prioritized diagnostic alert with supporting evidence directly in their EHR workflow. Average time from data receipt to alert: 87 seconds.
Ready to accelerate diagnosis at your institution? Contact our clinical partnerships team.
Pegasi is deployed across oncology departments in Houston, Dallas, and Boston. Our clinical team provides hands-on onboarding and ongoing model tuning to fit your patient population.